AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 144 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,161,849 | -31.6% | 2,644,988 | -49.8% | 0.94% | -30.8% |
| Q2 2023 | $16,322,278 | +126.6% | 5,265,251 | +1.6% | 1.36% | +171.9% |
| Q1 2023 | $7,204,434 | +335.7% | 5,183,046 | +523.7% | 0.50% | +246.2% |
| Q4 2022 | $1,653,610 | -82.5% | 830,960 | -82.3% | 0.14% | -82.3% |
| Q3 2022 | $9,475,440 | -45.8% | 4,690,812 | -14.6% | 0.82% | -33.9% |
| Q2 2022 | $17,471,810 | -23.7% | 5,494,280 | +0.1% | 1.24% | -29.4% |
| Q1 2022 | $22,899,542 | -25.8% | 5,491,497 | -14.7% | 1.76% | -10.8% |
| Q4 2021 | $30,850,340 | -15.7% | 6,440,572 | -6.0% | 1.97% | -22.4% |
| Q3 2021 | $36,578,114 | +27.0% | 6,849,834 | +21.8% | 2.54% | +32.3% |
| Q2 2021 | $28,798,592 | -10.0% | 5,624,725 | +18.3% | 1.92% | -20.2% |
| Q1 2021 | $32,004,380 | +494.4% | 4,755,480 | +303.6% | 2.41% | +280.7% |
| Q4 2020 | $5,384,159 | -47.8% | 1,178,153 | -55.6% | 0.63% | -72.4% |
| Q3 2020 | $10,306,087 | +144.2% | 2,656,208 | +199.6% | 2.29% | +295.5% |
| Q2 2020 | $4,220,154 | – | 886,587 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |